Director/PDMR Shareholding

Cropper(James) PLC
21 December 2023
 

James Cropper plc

(the "Company")

 

Director/PDMR Shareholding

 

The Company has been notified that on 21 December 2023, Patrick Willink (Chief Innovation Officer) purchased 3,626 Ordinary Shares of 25p each ("Shares") in the Company.   The Shares were purchased from a family trust of which Patrick Willink is a trustee. 

 

As a result of the transaction, Patrick Willink's beneficial interest in the Company has increased by 3,626 Shares, and his non-beneficial interest has decreased by 3,626 shares.  Patrick Willink's interests in the Company are currently as follows:

 


Number of shares

% of issued share capital

Beneficial shareholding

61,705

0.65%

Non-beneficial shareholding

108,058

1.13%

 

Patrick Willink and members of the Cropper, Willink and Acland families are deemed to act in concert and are regarded by the Takeover Panel as being members of a concert party as detailed in the Company's circular to shareholders dated 30 June 2015 (the "Concert Party").  The Concert Party has a collective interest in 3,598,609 Ordinary Shares representing 37.7% of the Company's issued share capital.



Enquiries

 

James Cropper plc

Matt Ratcliffe, General Counsel and Company Secretary

Tel: +44 (0) 1539 722 002

 

Shore Capital - (NOMAD and Broker)

Robert Finlay, Henry Willcocks, Lucy Bowden

Tel: +44 (0) 7601 6100

 

Buchanan Communications - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

 

The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):

1.

Details of person discharging managerial responsibilities/person closely associated

 

a)

Name

Patrick Willink

2.

 

Reason for the notification

a)

Position/status

Chief Innovation Officer

 

b)

Initial notification/amendment

Initial Notification

3.

Details of the issuer

 

a)

Name

James Cropper plc

 

b)

Legal Entity Identifier

213800XM78VTDYGBRM93

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the

financial instrument

Ordinary Shares of 25 pence each

b)

Identification code of the Financial Instrument

GB0002346053

c)

Nature of the

transaction

Purchase of Ordinary Shares

d)

Currency

GBP

 

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£6.30

3,626



 

f)

Aggregated

information

-      volume

-      Price

-      Total

 

 

 

3,626

£6.30

£22,843.80

g)

Date of the transaction

21 December 2023

h)

Place of the transaction

Outside trading venue 

 

 

 

1.

Details of person discharging managerial responsibilities/person closely associated

 

a)

Name

Patrick Willink (as trustee of a family trust)

2.

 

Reason for the notification

a)

Position/status

Chief Innovation Officer

 

b)

Initial notification/amendment

Initial Notification

3.

Details of the issuer

 

a)

Name

James Cropper plc

 

b)

Legal Entity Identifier

213800XM78VTDYGBRM93

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the

financial instrument

Ordinary Shares of 25 pence each

b)

Identification code of the Financial Instrument

GB0002346053

c)

Nature of the

transaction

Sale of Ordinary Shares

d)

Currency

GBP

 

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£6.30

3,626



 

f)

Aggregated

information

-      volume

-      Price

-      Total

 

 

 

3,626

£6.30

£22,843.80

g)

Date of the transaction

21 December 2023

h)

Place of the transaction

Outside trading venue 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings